100 related articles for article (PubMed ID: 22260023)
1. [Construction and immunological analysis of a combined multi-epitope vaccine against EGFR/HER2].
Hu CP; Cai XT; Lu WG; Wang ZG; Ji XY; Cao P
Yao Xue Xue Bao; 2011 Nov; 46(11):1326-31. PubMed ID: 22260023
[TBL] [Abstract][Full Text] [Related]
2. Construction of prokaryotic expression system of TGF-beta1 epitope gene and identification of recombinant fusion protein immunity.
Guo YH; Hao ZM; Luo JY; Wang JH
World J Gastroenterol; 2005 Oct; 11(40):6389-94. PubMed ID: 16419171
[TBL] [Abstract][Full Text] [Related]
3. [Construction and prokaryotic expression of recombinant gene EGFRvIII HBcAg and immunogenicity analysis of the fusion protein].
Duan XY; Wang JS; Guo YM; Han JL; Wang QY; Yang GX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jan; 23(1):21-4. PubMed ID: 17210099
[TBL] [Abstract][Full Text] [Related]
4. Induction of Humoral and Cellular Immune Responses in Mice by Multiepitope Vaccines Composing of Both T and B Lymphocyte Epitopes of MAGE-A3 which are Recombined into HBcAg.
Chen Q; Li W; Wang P; Shao H; Ding Y; Wang W; Cen D; Cai Y; Xue X; Zhang L; Zhu G
Protein Pept Lett; 2017; 24(10):947-954. PubMed ID: 28641561
[TBL] [Abstract][Full Text] [Related]
5. [Antitumor effect of EGFRvIII/HBcAg recomibinant vaccine on murine transplanted tumor].
Duan XY; Wang JS; Guo YM; Wang P; Wang QY; Yang GX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):600-2. PubMed ID: 17618576
[TBL] [Abstract][Full Text] [Related]
6. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice].
Li L; Tian YJ; Shen H; Zhao XP; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):275-9. PubMed ID: 19403026
[TBL] [Abstract][Full Text] [Related]
7. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
[TBL] [Abstract][Full Text] [Related]
8. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
[TBL] [Abstract][Full Text] [Related]
9. [Construction and immunogenicity analysis of tumor peptide vaccine P64k-EGFR(262-328); targeting the dimmerization interface of EGFR].
Zhao L; Wu M; Chen Z; Li H; Zhou L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):647-51. PubMed ID: 23746251
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of the epitope of the foot-and-mouth disease virus fused with a hepatitis B core protein as expressed in transgenic tobacco.
Huang Y; Liang W; Wang Y; Zhou Z; Pan A; Yang X; Huang C; Chen J; Zhang D
Viral Immunol; 2005; 18(4):668-77. PubMed ID: 16359233
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
Schödel F; Peterson D; Milich D
Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
[TBL] [Abstract][Full Text] [Related]
12. [Construction of recombinant plasmid pYTA/Abeta-HBcAg and its expression in E.coli].
Feng GF; Hu HT; Dong WJ; Wang QY; Yang GX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):671-4. PubMed ID: 15555431
[TBL] [Abstract][Full Text] [Related]
13. [Biological effects of immune serum from fusion protein of beta-amyloid peptide and HbcAg/MIR on AD transgeneic cells].
Liu ZH; Feng GF; Li YY; Ma YB; Hu HT
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):608-12. PubMed ID: 17718422
[TBL] [Abstract][Full Text] [Related]
14. [Prokaryotic expression and immunogenicity of the chimeric HBcAg containing Aβ(1-15)].
Feng G; Jin H; Wang W; Qian Y; Wang Q; Yang G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 37(3):290-5. PubMed ID: 22561498
[TBL] [Abstract][Full Text] [Related]
15. [Prokaryotic expression and immunogenicity analysis of the chimeric HBcAg containing APP beta cleavage site peptide and Aβ(1-15);].
Feng GF; Wang JY; Jin H; Wang WX; Qian YH; Yang WN; Wang QY; Yang GX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Nov; 27(11):1169-72. PubMed ID: 22078439
[TBL] [Abstract][Full Text] [Related]
16. [Construction and prokaryotic expression of recombinant gene c-Abeta-c and the immunogenicity analysis of the fusion protein].
Feng GF; Hu HT; Li YY; Han H; Wang QY; Yang GX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Sep; 21(5):533-7. PubMed ID: 16143050
[TBL] [Abstract][Full Text] [Related]
17. [Immunotherapeutic effect of recombinant EGFR phage vaccine on tumors].
Liu D; Tang L; Zhou CC; Tan LS
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):728-32. PubMed ID: 17366781
[TBL] [Abstract][Full Text] [Related]
18. Development of recombinant Salmonellae expressing hybrid hepatitis B virus core particles as candidate oral vaccines.
Schödel F; Kelly SM; Peterson D; Milich D; Hughes J; Tinge S; Wirtz R; Curtiss R
Dev Biol Stand; 1994; 82():151-8. PubMed ID: 7958469
[TBL] [Abstract][Full Text] [Related]
19. Expression and Characterization of the Extracellular Domain of Human HER2 from Escherichia Coli, and Production of Polyclonal Antibodies Against the Recombinant Proteins.
Sun Y; Feng X; Qu J; Han W; Liu Z; Li X; Zou M; Zhen Y; Zhu J
Appl Biochem Biotechnol; 2015 Jun; 176(4):1029-43. PubMed ID: 25906688
[TBL] [Abstract][Full Text] [Related]
20. [Construction of the expression vector pET32a/His MBL-CLR and its expression in E.coli].
Cai XM; Zuo DM; Zhao N; Zhang LY; Chen ZL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jan; 23(1):25-7, 31. PubMed ID: 17210100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
